Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.29 Million AUD | -23.11% |
| 2023 | 1.68 Million AUD | -6.9% |
| 2022 | 1.8 Million AUD | -15.96% |
| 2021 | 2.15 Million AUD | 32.8% |
| 2020 | 1.62 Million AUD | -85.94% |
| 2019 | 11.52 Million AUD | -8.88% |
| 2018 | 12.64 Million AUD | 6.97% |
| 2017 | 11.82 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.22 Million AUD | -27.08% |
| 2024 FY | 1.29 Million AUD | -23.11% |
| 2024 Q4 | 1.29 Million AUD | 5.45% |
| 2023 Q2 | 1.21 Million AUD | -32.86% |
| 2023 Q4 | 1.68 Million AUD | 38.65% |
| 2023 FY | 1.68 Million AUD | -6.9% |
| 2022 Q4 | 1.8 Million AUD | -16.1% |
| 2022 FY | 1.8 Million AUD | -15.96% |
| 2022 Q2 | 2.15 Million AUD | 0.18% |
| 2021 Q4 | 2.15 Million AUD | 13.93% |
| 2021 Q2 | 1.88 Million AUD | 16.56% |
| 2021 FY | 2.15 Million AUD | 32.8% |
| 2020 FY | 1.62 Million AUD | -85.94% |
| 2020 Q4 | 1.62 Million AUD | -93.55% |
| 2020 Q2 | 25.09 Million AUD | 117.84% |
| 2019 Q4 | 11.52 Million AUD | 0.0% |
| 2019 FY | 11.52 Million AUD | -8.88% |
| 2018 FY | 12.64 Million AUD | 6.97% |
| 2017 FY | 11.82 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 97.363% |
| Adherium Limited | 3.4 Million AUD | 62.005% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 91.241% |
| Anteris Technologies Ltd | 17.03 Million AUD | 92.403% |
| Control Bionics Limited | 2.75 Million AUD | 53.095% |
| CardieX Limited | 8.56 Million AUD | 84.883% |
| Compumedics Limited | 22.14 Million AUD | 94.156% |
| Cochlear Limited | 904.6 Million AUD | 99.857% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 81.375% |
| Cyclopharm Limited | 13.65 Million AUD | 90.521% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 76.274% |
| Nova Eye Medical Limited | 8.55 Million AUD | 84.864% |
| HeraMED Limited | 1.5 Million AUD | 14.047% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 94.823% |
| ImpediMed Limited | 6.24 Million AUD | 79.266% |
| InhaleRx Limited | 911.41 Thousand AUD | -42.02% |
| LBT Innovations Limited | 5.5 Million AUD | 76.5% |
| Micro-X Limited | 12.63 Million AUD | 89.755% |
| Neurotech International Limited | 314.69 Thousand AUD | -311.311% |
| OncoSil Medical Limited | 1.98 Million AUD | 34.692% |
| PolyNovo Limited | 37.04 Million AUD | 96.506% |
| Respiri Limited | 3.55 Million AUD | 63.579% |
| SomnoMed Limited | 24.78 Million AUD | 94.777% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 87.803% |
| Uscom Limited | 2.07 Million AUD | 37.577% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | 53.219% |